Editors
Editor-in-Chief (South Africa)
PROF AJ BRINK
Assistant Editor
Prof JAMES KER (JUN)
Regional Editor (Cameroon)
Prof JC Mbanya
Regional Editor (Kenya)
Dr F Bukachi
Regional Editor (South Africa)
PROF R DELPORT
Editorial Board
prof PA Brink
Experimental & Laboratory Cardiology
PROF R DELPORT
Chemical Pathology
PROF MR ESSOP
Haemodynamics, Heart Failure &
Valvular Heart Disease
DR OB FAMILONI
Clinical Cardiology
DR V GRIGOROV
Invasive Cardiology & Heart Failure
PROF J KER (SEN)
Hypertension, Cardiomyopathy,
Cardiovascular Physiology
DR J LAWRENSON
Paediatric Heart Disease
PROF A LOCHNER
Biochemistry/Laboratory Science
PROF BM MAYOSI
Chronic Rheumatic Heart Disease
DR MT MPE
Cardiomyopathy
PROF DP NAIDOO
Echocardiography
PROF B RAYNER
Hypertension/Society
PROF MM SATHEKGE
Nuclear Medicine/Society
PROF YK SEEDAT
Diabetes & Hypertension
PROF H DU T THERON
Invasive Cardiology
International Advisory
Board
PROF DAVID CELEMAJER
Australia (Clinical Cardiology)
PROF KEITH COPELIN FERDINAND
USA (General Cardiology)
DR SAMUEL KINGUE
Cameroon (General Cardiology)
DR GEORGE A MENSAH
USA (General Cardiology)
PROF WILLIAM NELSON
USA (Electrocardiology)
DR ULRICH VON OPPEL
Wales (Cardiovascular Surgery)
PROF PETER SCHWARTZ
Italy (Dysrhythmias)
PROF ERNST VON SCHWARZ
USA (Interventional Cardiology)
Publishing Consultant
Mike Gibbs
AFRICA
ISSN 1995-1892 (print)
ISSN 1680-0745 (online)
Cardiovascular Journal of Africa
CONTENTS
INDEXED AT SCISEARCH (SCI), PUBMED AND SABINET
VOL 21, NO 6. NOVEMBER / DECEMBER 2010
Editorial
309 Associations of serum C-reactive protein with physical activity, fitness and fatness in
South African adolescents
HS Kruger
Cardiovascular Topics
311 Outcomes of stenting with overlapping drug-eluting stents versus overlapping
drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
SE Kassaian • M Salarifar • M Raissi Dehkordi • M Alidoosti • E Nematipour • HR Poorhosseini •
AM Hajizeinali • D Kazemisaleh • A Sharafi • M Mahmoodian • N Paydari • AV Farahani
316 Significant differences between serum CRP
levels in children in different categories
of physical activity: the PLAY study
B Harmse • HS Kruger
Special report
323 New anti-coagulant therapies set to revitalise
clinical haemotology practice
Annual meeting of the Southern African
Society of Thrombosis and Haemostasis
J Aalbers • P Wagenaar • E Klug
Case Reports
327 Mitral valve prolapse and conduction
disturbances: the forgotten association
A D’Aloia • E Vizzardi • E Antonioli • E Chiari •
A Curnis • L Dei Cas
329 Post-infarction ventricular septal defect:
triggered by Valsalva manoeuvre?
M Baskurt • N Turhan • A Hatemi • M Cani̇
koglu •
B Karadag • S Kucukog
It's the
shell that
makes
safer.
R
Safety-Coated
R
81mg
The ORIGINAL low dose aspirin
for optimum cardio-protection
Hp
Each tablet contains Aspirin 81mg. Reg.No.: 29/2.7/0767
Pharmafrica (Pty) Ltd, 33 Hulbert Road, New Centre, Johannesburg 2001
Under licence from Goldshield Pharmaceuticals Ltd. U.K.
